Search
Advanced Search

Lp Pro Kardiovaskulární Systém Xx. - Evolocumab

ca

General Information
   Oct 1, 2024
   Czech
   Other
36100000 INR
   published: Oct 1, 2024

Original Text

DetailN006/24/V00019419LP pro kardiovaskulární systém XX. - Evolocumab AwardedInstitut klinické a experimentální medicíny07/29/2024, 01:00 PMDetailHomePublic ProcurementsLP pro kardiovaskulární systém XX. - Evolocumab LP pro kardiovaskulární systém XX. - Evolocumab InformationDocumentsResultAUTHORIZED SECTIONBasic InformationPROCUREMENT PROCEDURE NAME
LP pro kardiovaskulární systém XX...
Subscription Options

Basic

Full

Corporate

$550/year

$1000/year

Price on request

Buy Buy Contact Us

Contract award information
   Amgen s.r.o.
Please note that this notice is for your information only.
We try our best to have the most accurate and up-to-date information available on our web site, but we cannot guarantee that all of the information provided is error-free.
If you have any suggestions for updates/corrections for this notice, please let us know.